LD

Loïc Dartois

Vice President Biopharma at SOPHiA GENETICS

Loïc Dartois, MBA, has a diverse and extensive work experience in the pharmaceutical and healthcare industry. Loïc'smost recent position was as the Vice President of Business Development BioPharma at SOPHiA GENETICS since February 2023. Prior to this, they served as the VP Pharma at Tribun Health, AI-Powered Pathology, from March 2022 to February 2023. Loïc also held the role of Senior Director of Business Development at Evidera from June 2017 to March 2022. Loïc gained experience at ICON plc as the Business Development Director - Real World Evidence from May 2016 to June 2017.

Before that, Loïc worked at Quintiles as the Associate Director of Business Development, Real World & Late Phase Research, where they specialized in peri- and post-approval studies from January 2014 to May 2016. Loïc'scareer also includes roles at OptumInsight as the Director of Global Business Development from July 2011 to December 2013, and at CEGEDIM as a Business Developer for Cegedim Strategic Data (CSD) Medical Research from September 2010 to August 2011. Loïc began their career as a Sales Manager at Synteract from January 2008 to August 2010 and as a Product Manager at sanofi-aventis in 2007.

Throughout their work experience, Loïc has developed expertise in areas such as business development, market access, real-world evidence, late-phase studies, and health economics and outcomes research.

Loïc Dartois, MBA, obtained their Master of Business Administration (MBA) degree from ESSEC Business School in 2021. Prior to that, in 2013, they earned a European Market Access University Diploma from Université Claude Bernard Lyon 1, specializing in Market Access, Health Technology Assessment (HTA), and Health Economics and Outcomes Research (HEOR). In 2007, Loïc completed the European Project Semester at DTU - Technical University of Denmark, focusing on Management. Loïc also holds a Master of Biotechnologies & Bioindustries Management from ESIEE PARIS, which they acquired in 2007, with a specialization in Management and Biotechnologies. Additionally, they obtained a Bachelor of Science degree in Biology from the Nottingham Trent University in 2004 and a Bachelor of Science degree in Biology from Université Paris-Est Créteil (UPEC) in 2004 as well. Loïc Dartois further enhanced their qualifications by obtaining a TOEIC certification from the TOEIC® Program in December 2019.

Links

Previous companies

Synteract logo
Sanofi logo
Cegedim SA logo
ICON logo
UnitedHealth Group logo
IQVIA logo

Timeline

  • Vice President Biopharma

    January 1, 2023 - present

  • Vice President Business Development Biopharma

    February, 2023

View in org chart